Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7875884 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL27698367 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL31080991 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL230952 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL2009107 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL8668755 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL4410050 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL10360428 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL11348771 | 1.00 | LSS (0.48) | LSSLMNADNM1TSHRTHRB | |
| SCHEMBL10407594 | 0.98 | LSS (0.46) | LSSLMNADNM1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1820843-B1 | Acidic cleaning concentrate for cleaning smooth, non-horizontal surfaces | WITTY CHEMIE GMBH & CO KG (DE) | 2014-05-28 | — | — | EP | claimed |
| US-20230190719-A1 | TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE | BIOHAVEN THERAPEUTICS LTD (US) | 2023-06-22 | — | — | US | disclosed |
| US-11648188-B1 | Aerosol sprayable color composition | AMERICAN SPRAYTECH, L.L.C. (US) | 2023-05-16 | — | — | US | disclosed |
| EP-4168116-A1 | TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE | Biohaven Therapeutics Ltd. (US) | 2023-04-26 | — | — | EP | disclosed |
| US-11389536-B2 | Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent | BioCurity Pharmaceuticals Inc. (US) | 2022-07-19 | — | — | US | disclosed |
| WO-2021262779-A1 | TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE | BIOHAVEN THERAPEUTICS LTD. (US) | 2021-12-30 | — | — | WO | disclosed |
| US-11185544-B2 | Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same | ST IP HOLDING AG (CH) | 2021-11-30 | — | — | US | disclosed |
| EP-3171879-B1 | PREVENTING AND TREATING INFLAMMATORY SKIN DISEASES | TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD (IL) | 2021-06-23 | — | — | EP | disclosed |
| US-20210052580-A1 | Combination Compositions and Therapies Comprising 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using Same | ZPNE GROUP GMBH (CH) | 2021-02-25 | — | — | US | disclosed |
| EP-3762104-A2 | COMBINATION COMPOSITIONS AND THERAPIES COMPRISING 4-METHYL-5-(PYRAZIN-2-YL)-3H-1,2-DITHIOLE-3-THIONE, AND METHODS OF MAKING AND USING SAME | ST IP Holding AG (CH) | 2021-01-13 | — | — | EP | disclosed |
| EP-0280445-A1 | Pitch control aid | W.R. Grace & Co.-Conn. (US) | 1988-08-31 | — | — | EP | disclosed |
| EP-0238635-A4 | NONIONIC FINE FABRIC DETERGENT COMPOSITION. | STALEY MFG CO A E (US) | 1988-01-07 | — | — | EP | disclosed |
| EP-0238635-A1 | NONIONIC FINE FABRIC DETERGENT COMPOSITION. | STALEY MFG CO A E (US) | 1987-09-30 | — | — | EP | disclosed |
| WO-1987002051-A1 | NONIONIC FINE FABRIC DETERGENT COMPOSITION | A. E. STALEY MANUFACTURING COMPANY (US) | 1987-04-09 | — | — | WO | disclosed |
| US-4606850-A | GLYCOSIDE, AMINE OXIDE AND QUATERNARY AMMONIUM HALIDE SURFACTANTS, DETERGENT BUILDER; LIQUID | A. E. STALEY MANUFACTURING COMPANY (US) | 1986-08-19 | — | — | US | disclosed |
| US-4264479-A | NONIONIC DETERGENT, TERTIARY AMINE OXIDE OR AMPHOTERIC DETERGENT, AND A QUATERNARY AMMONIUM HALIDE | FLANAGAN JOHN J | 1981-04-28 | — | — | US | disclosed |
| US-4248862-A | Immunogenic cell envelope preparations | THE SECRETARY OF STATE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1981-02-03 | — | — | US | disclosed |
| US-4203872-A | NONIONIC DETERGENT, TERTIARY AMINE OXIDE OR AMPHOTERIC DETERGENT AND A QUATERNARY AMMONIUM HALIDE | FLANAGAN JOHN J | 1980-05-20 | — | — | US | disclosed |
| US-4174304-A | NONIONIC SURFACTANTS, AMINE OXIDE, QUATERANARY AMMONIUM HALIDE | Bullen Chemical Company Midwest, Inc. (US) | 1979-11-13 | — | — | US | disclosed |
| US-4065409-A | Hard surface detergent composition | CORPORATE BRANDS, INC. (US) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11185544-B2 | Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same | TAS2R5, TAS2R3, TAS2R16 | LSS 1192/4885LMNA 4360/4885DNM1 3602/4885 |
| US-20230190719-A1 | TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE | TRPV1, PNN, SLC18A2 | LSS 550/4885LMNA 1688/4885DNM1 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.